Topicort Topical Spray, Solution 0.25pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Topicort: Topical spray, solution (0.25%)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png
Topicort 0.25% Topical Spray

What is this Medicine?

DESOXIMETASONE (des ox i MET a sone) is a corticosteroid. It is used to treat skin problems that may cause itching, redness, and swelling.

CVS Pharmacy Patient Statistics for Topicort: Topical spray, solution(0.25%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Topicort 0.25% Topical Spray

NDC: 516725281
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Contact Dermatitis, Keloids, Urticaria, Alopecia, Rhus Dermatitis, Necrobiosis Lipoidica Diabeticorum, Eczema, Pemphigus, Sarcoidosis, Discoid Lupus Erythematosus, Granuloma Annulare, Seborrheic Dermatitis, Pruritus, Pityriasis Rosea, Psoriasis, Lichen Striatus, Lichen Simplex, Atopic Dermatitis, Lichen Planus, Xerosis, Exfoliative Dermatitis

Storage Information
Flammable, keep away from heat and flame
Discard opened bottle after 30 days
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Topicort 0.25% Topical Spray
Close All Sections Show

Reported Side Effects for Topicort 0.25% Topical Spray

Close Show
Inflamed Hair Follicles Incidence:
0.8%*
Severity: MILD
Onset: DELAYED
Rash With Pustules Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Topicort

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.